Heart Failure (HF) is a common disease that affects an estimated global population of over 40 million. It is the most frequent cause of hospitalizations in patients over the age of 65, placing a considerable financial and social burden on patients, healthcare providers, and care providers. Accurate clinical assessment of HF and cost-effective management strategies are critical in improving patient outcomes and reducing the socioeconomic burden of this disease.
In this podcast episode, we will have a conversation between Dr. Christopher deFilippi, a cardiologist at the Inova Heart and Vascular Institute, and Dr. Ivan Salgo to learn more about heart failure, how it is diagnosed, and the value of using the in-vitro diagnostic test NT-proBNP.
About our Speaker:
Dr. Christopher deFilippi is a distinguished cardiologist who currently works at the Inova Heart and Vascular Institute (IHVI) in Fairfax, Virginia as the Vice-Chair of Academic Affairs.
In his oversight of clinical research, he has built IHVI to be a national leader in site-based research. He serves on the Editorial boards of Circulation, JACC, and JACC: Heart Failure. He is an Associate Editor for the Journal of Applied Laboratory Medicine. His research is focused on evaluating in-vitro diagnostics and proteomics discovery for diagnosis, prognosis, and therapy guidance across the spectrum of health from detection of preclinical cardiovascular disease to diagnosis and treatment in the critically ill.
More Episodes
2022-03-28
480
2022-01-19
541
2021-12-15
395
2021-09-30
920
2021-08-18
1.4k
2021-07-22
621
2021-04-14
1.4k
2021-02-18
663
2021-01-20
970
2020-10-28
981
2020-09-10
979
2020-07-30
962
Get this podcast on your
phone, FREE
